featured
ESMO 2018: Radium-223 Plus Abiraterone for Castration-Refractory Prostate Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles: